Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 28, 2013	Sep. 29, 2012
Operating Activities:
Net income	$ 184.5	$ 118.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	38.5	36.5
Unrealized foreign exchange loss	2.5	0
Equity compensation	11.9	11.3
Amortization of deferred debt costs	0.6	0.7
Premium on senior notes	6.3	0
Net gains on disposal of assets, including insurance recoveries	0.8	8.0
Provision for bad debts	9.3	8.4
Write-down of inventories	11.7	11.1
Non-cash impact of re-engineering and impairment costs	0	76.9
Net change in deferred income taxes	(18.5)	(3.1)
Excess tax benefits from share-based payment arrangements	(13.6)	(11.9)
Changes in assets and liabilities:
Accounts and notes receivable	(29.2)	(33.3)
Inventories	(64.8)	(47.1)
Non-trade amounts receivable	(3.2)	1.1
Prepaid expenses	(5.4)	(8.8)
Other assets	4.2	(4.2)
Accounts payable and accrued liabilities	(8.3)	(18.9)
Income taxes payable	(5.8)	(20.1)
Other liabilities	2.2	0.3
Proceeds from insurance recoveries, net of costs	0	0.2
Net cash impact from hedging activity	3.8	1.9
Other	0.1	0
Net cash provided by operating activities	126.0	111.5
Investing Activities:
Capital expenditures	(42.9)	(51.0)
Proceeds from disposal of property, plant and equipment	8.4	9.8
Net cash used in investing activities	(34.5)	(41.2)
Financing Activities:
Dividend payments to shareholders	(84.9)	(57.5)
Net proceeds from issuance of senior notes	200.0	0
Proceeds from exercise of stock options	18.9	9.7
Repurchase of common stock	(303.7)	(104.3)
Repayment of capital lease obligations	(1.9)	(1.8)
Net change in short-term debt	87.3	47.4
Debt issuance costs	(2.1)	0
Excess tax benefits from share-based payment arrangements	13.6	11.9
Net cash used in financing activities	(72.8)	(94.6)
Effect of exchange rate changes on cash and cash equivalents	(12.5)	(0.1)
Net change in cash and cash equivalents	6.2	(24.4)
Cash and cash equivalents at beginning of year	119.8	138.2
Cash and cash equivalents at end of period	$ 126.0	$ 113.8